Citations (50)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
H. Wijkström, S.M. Cohen, R.A. Gardiner, T. Kakizoe, M. Schoenberg, G. Steineck & K. Tobisu. (2000) Prevention and Treatment of Urothelial Premalignant and Malignant Lesions. Scandinavian Journal of Urology and Nephrology 34:205, pages 116-135.
Read now
Read now
Articles from other publishers (49)
Angela B. Smith, Arjun V. Balar, Matthew I. Milowsky & Ronald C. Chen. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
1382
1400.e4
.
. (2018) 2 - Epidemiologia E Classificazione Istopatologica. Tumori Journal 104:2_suppl, pages S8-S13.
Crossref
Crossref
Sven Wach, Katrin Weigelt, Bernhard Michalke, Verena Lieb, Robert Stoehr, Bastian Keck, Arndt Hartmann, Bernd Wullich, Helge Taubert & Anwar Chaudhri. (2018) Diagnostic potential of major and trace elements in the serum of bladder cancer patients. Journal of Trace Elements in Medicine and Biology 46, pages 150-155.
Crossref
Crossref
Francesca Khani & Brian D. Robinson. (2017) Precursor Lesions of Urologic Malignancies. Archives of Pathology & Laboratory Medicine 141:12, pages 1615-1632.
Crossref
Crossref
Carlos Cordon-Cardo & Adolfo Firpo-Betancourt. 2016. Holland-Frei Cancer Medicine. Holland-Frei Cancer Medicine
1
9
.
Sean McAdams & Michael C. Risk. 2015. Management of Bladder Cancer. Management of Bladder Cancer
45
57
.
Angela Smith, Arjun V. Balar, Matthew I. Milowsky & Ronald C. Chen. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
1445
1462.e4
.
Marino E. Leon, Dahui Qin & Debra L. Zynger. 2014. Molecular Pathology and Diagnostics of Cancer. Molecular Pathology and Diagnostics of Cancer
329
340
.
David J. DeGraff, Justin M. Cates, Joshua R. Mauney, Peter E. Clark, Robert J. Matusik & Rosalyn M. Adam. (2013) When urothelial differentiation pathways go wrong: Implications for bladder cancer development and progression. Urologic Oncology: Seminars and Original Investigations 31:6, pages 802-811.
Crossref
Crossref
Hemamali Samaratunga, Guido Martignoni, Lars Egevad & Brett Delahunt. (2013) Premalignant lesions of the urinary bladder. Pathology 45:3, pages 243-250.
Crossref
Crossref
DIMITRA P. VAGELI, STAVROS GIANNOPOULOS, SOTIRIOS G. DOUKAS, CHRISTOS KALAITZIS, STILIANOS GIANNAKOPOULOS, ALEXANDRA GIATROMANOLAKI, GEORGE K. KOUKOULIS & STAVROS TOULOUPIDIS. (2013) Mismatch repair hMSH2, hMLH1, hMSH6 and hPMS2 mRNA expression profiles in precancerous and cancerous urothelium. Oncology Letters 5:1, pages 283-294.
Crossref
Crossref
Tomasz Drewa, Jan Adamowicz & Arun Sharma. (2012) Tissue engineering for the oncologic urinary bladder. Nature Reviews Urology 9:10, pages 561-572.
Crossref
Crossref
David P. WoodJr.Jr.. 2012. Campbell-Walsh Urology. Campbell-Walsh Urology
2309
2334.e6
.
Maria José Cabello, Laura Grau, Noreli Franco, Esteban Orenes, Miguel Alvarez, Ana Blanca, Oscar Heredero, Alberto Palacios, Manuel Urrutia, Jesus María Fernández, Antonio López-Beltrán & Marta Sánchez-Carbayo. (2011) Multiplexed Methylation Profiles of Tumor Suppressor Genes in Bladder Cancer. The Journal of Molecular Diagnostics 13:1, pages 29-40.
Crossref
Crossref
Javier Lerena, Lucas Krauel, Luis García-Aparicio, Santiago Vallasciani, Mariona Suñol & Joan Rodó. (2010) Transitional cell carcinoma of the bladder in children and adolescents: Six-case series and review of the literature. Journal of Pediatric Urology 6:5, pages 481-485.
Crossref
Crossref
Guang-Qian Xiao & Pamela D. Unger. (2010) Renal pelvic urothelial carcinoma with divergent morphology. Annals of Diagnostic Pathology 14:2, pages 74-80.
Crossref
Crossref
Feng He, Lan Mo, Xiao-Yong Zheng, Changkun Hu, Herbert Lepor, Eva Y-H.P. Lee, Tung-Tien Sun & Xue-Ru Wu. (2009) Deficiency of pRb Family Proteins and p53 in Invasive Urothelial Tumorigenesis. Cancer Research 69:24, pages 9413-9421.
Crossref
Crossref
Xue-Ru Wu, Xiang-Peng Kong, Angel Pellicer, Gert Kreibich & Tung-Tien Sun. (2009) Uroplakins in urothelial biology, function, and disease. Kidney International 75:11, pages 1153-1165.
Crossref
Crossref
Ainel Aleman, Virginia Cebrian, Miguel Alvarez, Virginia Lopez, Esteban Orenes, Lidia Lopez-Serra, Ferran Algaba, Joaquin Bellmunt, Antonio López-Beltrán, Pilar Gonzalez-Peramato, Carlos Cordon-Cardo, Javier García, Javier García del Muro, Manel Esteller & Marta Sánchez-Carbayo. (2008) Identification of PMF1 Methylation in Association with Bladder Cancer Progression. Clinical Cancer Research 14:24, pages 8236-8243.
Crossref
Crossref
V Cebrian, M Alvarez, A Aleman, J Palou, J Bellmunt, P Gonzalez-Peramato, C Cordón-Cardo, J García, JM Piulats & M Sánchez-Carbayo. (2008) Discovery of myopodin methylation in bladder cancer. The Journal of Pathology 216:1, pages 111-119.
Crossref
Crossref
Ming Yin, Sheldon Bastacky, Anil V. Parwani, Teresa McHale & Rajiv Dhir. (2008) p16ink4 immunoreactivity is a reliable marker for urothelial carcinoma in situ. Human Pathology 39:4, pages 527-535.
Crossref
Crossref
A Aleman, L Adrien, L Lopez-Serra, C Cordon-Cardo, M Esteller, T J Belbin & M Sanchez-Carbayo. (2007) Identification of DNA hypermethylation of SOX9 in association with bladder cancer progression using CpG microarrays. British Journal of Cancer 98:2, pages 466-473.
Crossref
Crossref
J. Álvarez Kindelán, J.P. Campos Hernández, A. López Beltrán & M.J. Requena Tapia. (2007) Clasificación de la OMS 2004 para los tumores vesicales: resumen y comentarios. Actas Urológicas Españolas 31:9, pages 978-988.
Crossref
Crossref
Cristina Magi-Galluzzi, Ming Zhou & Jonathan I. Epstein. 2007. Genitourinary Pathology. Genitourinary Pathology
154
224
.
D Dhawan, FC Hamdy, I Rehman, J Patterson, SS Cross, KM Feeley, Y Stephenson, M Meuth & JWF Catto. (2006) Evidence for the early onset of aberrant promoter methylation in urothelial carcinoma. The Journal of Pathology 209:3, pages 336-343.
Crossref
Crossref
Thomas Hofmann, Ruth Knüchel-Clarke, Arndt Hartmann, Robert Stöhr, Derya Tilki, Michael Seitz, Alexander Karl, Christian Stief & Dirk Zaak. (2006) Clinical Implications of the 2004 WHO Histological Classification on Non-Invasive Tumours of the Urinary Bladder. EAU-EBU Update Series 4:3, pages 83-95.
Crossref
Crossref
Riccardo Bartoletti, Tommaso Cai, Maurizio Dal Canto, Vieri Boddi, Gabriella Nesi & Mauro Piazzini. (2006) Multiplex Polymerase Chain Reaction for Microsatellite Analysis of Urine Sediment Cells: A Rapid and Inexpensive Method for Diagnosing and Monitoring Superficial Transitional Bladder Cell Carcinoma. Journal of Urology 175:6, pages 2032-2037.
Crossref
Crossref
Margaret A. Knowles. (2006) Molecular subtypes of bladder cancer: Jekyll and Hyde or chalk and cheese?. Carcinogenesis 27:3, pages 361-373.
Crossref
Crossref
Louis S. Liou. (2006) Urothelial cancer biomarkers for detection and surveillance. Urology 67:3, pages 25-33.
Crossref
Crossref
M Aaboe, N Marcussen, K M-E Jensen, T Thykjaer, L Dyrskjøt & T F Ørntoft. (2005) Gene expression profiling of noninvasive primary urothelial tumours using microarrays. British Journal of Cancer 93:10, pages 1182-1190.
Crossref
Crossref
Lan Mo, Jin Cheng, Eva Y.-H. P. Lee, Tung-Tien Sun & Xue-Ru Wu. (2005) Gene deletion in urothelium by specific expression of Cre recombinase. American Journal of Physiology-Renal Physiology 289:3, pages F562-F568.
Crossref
Crossref
Xue-Ru Wu. (2005) Urothelial tumorigenesis: a tale of divergent pathways. Nature Reviews Cancer 5:9, pages 713-725.
Crossref
Crossref
Rodolfo Montironi & Antonio Lopez-Beltran. (2016) The 2004 WHO Classification of Bladder Tumors: A Summary and Commentary. International Journal of Surgical Pathology 13:2, pages 143-153.
Crossref
Crossref
R. Mazzucchelli, R. Montironi, A. López Beltran & A.V. Bono. (2018) The 2004 WHO Classification of Non-Invasive Papillary Neoplasms of the Urinary Bladder (Also Referred to as WHO(2004)/ISUP). Urologia Journal 72:2, pages 224-228.
Crossref
Crossref
Salvador Peláez, Isabel Hierro, Salvador Oña, Lorenzo Alonso & Alfredo Matilla. (2004) Relación entre la exposición a pesticidas y el desarrollo de carcinoma urotelial vesical superficial de bajo grado. Medicina Clínica 123:15, pages 571-574.
Crossref
Crossref
Robert Stoehr, Christoph Wissmann, Hiromu Suzuki, Ruth Knuechel, Rene C Krieg, Eva Klopocki, Edgar Dahl, Peter Wild, Hagen Blaszyk, Guido Sauter, Ronald Simon, Ruediger Schmitt, Dirk Zaak, Ferdinand Hofstaedter, Andre Rosenthal, Stephen B Baylin, Christian Pilarsky & Arndt Hartmann. (2004) Deletions of chromosome 8p and loss of sFRP1 expression are progression markers of papillary bladder cancer. Laboratory Investigation 84:4, pages 465-478.
Crossref
Crossref
Jing Gao, Hong-Ying Huang, Joanne Pak, Jin Cheng, Zhong-Ting Zhang, Ellen Shapiro, Angel Pellicer, Tung-Tien Sun & Xue-Ru Wu. (2004) p53 deficiency provokes urothelial proliferation and synergizes with activated Ha-ras in promoting urothelial tumorigenesis. Oncogene 23:3, pages 687-696.
Crossref
Crossref
M.A. Demir, W. Ryd, F. Aldenborg & S. Holmang. (2003)
Cytopathological expression of different types of urothelial carcinoma
in situ
in urinary bladder washings
. BJU International 92:9, pages 906-910.
Crossref
Crossref
S.Machele Donat. (2003) Evaluation and follow-up strategies for superficial bladder cancer. Urologic Clinics of North America 30:4, pages 765-776.
Crossref
Crossref
Kimberly M. Rieger‐Christ, Arthur Mourtzinos, Peter J. Lee, Ralph M. Zagha, Jason Cain, Mark Silverman, John A. Libertino & Ian C. Summerhayes. (2003) Identification of fibroblast growth factor receptor 3 mutations in urine sediment DNA samples complements cytology in bladder tumor detection. Cancer 98:4, pages 737-744.
Crossref
Crossref
Martina Tinzl & Michael Marberger. (2003) Urinary Markers for Detecting Bladder Cancer. EAU Update Series 1:2, pages 64-70.
Crossref
Crossref
Bas W.G. van RhijnAndré N. VisTheo H. van der KwastWim J. KirkelsFrançois RadvanyiEngelbert C.M. OomsDominique K. ChopinEgbert R. BoevéAdriaan C. JöbsisEllen C. Zwarthoff. (2003) Molecular Grading of Urothelial Cell Carcinoma With Fibroblast Growth Factor Receptor 3 and MIB-1 is Superior to Pathologic Grade for the Prediction of Clinical Outcome. Journal of Clinical Oncology 21:10, pages 1912-1921.
Crossref
Crossref
J.G. LORENZO-ROMERO, A.S. SALINAS-SÁNCHEZ, J.M. GIMÉNEZ-BACHS, F. SÁNCHEZ-SÁNCHEZ, J. ESCRIBANO-MARTÍNEZ, M. SEGURA-MARTÍN, I.R. HERNÁNDEZ-MILLÁN & J.A. VIRSEDA-RODRÍGUEZ. (2003) Prognostic Implications of p53 Gene Mutations in Bladder Tumors. Journal of Urology 169:2, pages 492-499.
Crossref
Crossref
Robert Stoehr, Peter Wild & Arndt Hartmann. (2003) Lasermicrodissection – An Important Prerequisite for the Molecular-genetic Analysis of Bladder Cancer. Pathology - Research and Practice 199:6, pages 355-362.
Crossref
Crossref
J.-Matthias Löhr. 2003. Krebsfrüherkennung. Krebsfrüherkennung
5
13
.
EC Obermann, K Junker, R Stoehr, W Dietmaier, D Zaak, J Schubert, F Hofstaedter, R Knuechel & A Hartmann. (2002) Frequent genetic alterations in flat urothelial hyperplasias and concomitant papillary bladder cancer as detected by CGH, LOH, and FISH analyses. The Journal of Pathology 199:1, pages 50-57.
Crossref
Crossref
Robert Stoehr, Ruth Knuechel, Joerg Boecker, Hagen Blaszyk, Ruediger Schmitt, Thomas Filbeck, Ferdinand Hofstaedter & Arndt Hartmann. (2002) Histologic-Genetic Mapping by Allele-Specific PCR Reveals Intraurothelial Spread of p53 Mutant Tumor Clones. Laboratory Investigation 82:11, pages 1553-1561.
Crossref
Crossref
PER-UNO MALMSTR??M, ZHI-PING REN, AMIR SHERIF, MANUEL de la TORRE, KENNETH WESTER & MAGNUS TH??RN. (2002) Early Metastatic Progression of Bladder Carcinoma: Molecular Profile of Primary Tumor and Sentinel Lymph Node. The Journal of Urology, pages 2240-2244.
Crossref
Crossref
PER-UNO MALMSTRÖM, ZHI-PING REN, AMIR SHERIF, MANUEL de la TORRE, KENNETH WESTER & MAGNUS THÖRN. (2002) Early Metastatic Progression of Bladder Carcinoma: Molecular Profile of Primary Tumor and Sentinel Lymph Node. Journal of Urology 168:5, pages 2240-2244.
Crossref
Crossref